Investing

Description The securities of Sarama Resources Ltd (‘SRR’) will be placed in trading halt at the request of SRR, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt…

Chromium is a metal for the modern age with a bright future. It is one of the more durable metals available, and is an integral component of stainless steel, which is used in infrastructure and…

John Feneck, portfolio manager and consultant at Feneck Consulting, shared his thoughts on gold’s post-US election price drop, saying it doesn’t mean the metal won’t thrive once Donald Trump takes office again. Feneck also gave…

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce it has been granted Human Research Ethics…

Description The suspension of trading in the securities of Jindalee Lithium Limited (‘JLL’) will be lifted immediately following the release by JLL of an announcement regarding a prefeasibility study and the receipt of a response…

The Russian government has imposed temporary restrictions on enriched uranium exports to the US. Announced on November 15, the move follows the US’ decision toban imports of Russian uranium. While the US legislation went into…

Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier Forum on 18th November 2024. This event will showcase the intersection between technology, health…

Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b clinical trial in dengue fever. All key data samples have been…

Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the company’s achievements while waiting for the completion of its listing on…

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that a clinical study featuring 68Ga-Trivehexin (68Ga-RAD…